Garrett Motion Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Garrett Motion Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2018	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	2,997	3,096	3,375	3,248	3,034	3,633	3,603	3,886	3,475	3,584
Cost of revenue	2,365	2,361	2,599	2,555	2,495	2,926	2,920	3,130	2,770	2,853
Gross profit	632	735	776	693	539	707	683	756	705	731
Selling, general and administrative	197	249	249	231	260	216	216	247	240	240
Interest expense	7	8	19	68	79	83	8	159
Interest income	16	14	7	7	3	1	2	7	3	4
Other non-operating income	5	18	8	-8	38	6	47	2	13	19
Pre-tax income	250	366	396	346	119	538	496	347	343	392
Income tax	51	1,349	-810	33	39	43	106	86	61	82
Net income	199	-983	1,206	313	80	495	390	261	282	310
EPS, basic	2.69	-13.27	16.28	4.20	1.06	1.69	0.75	-0.31	1.27	1.55
EPS, diluted	2.69	-13.27	16.21	4.12	1.05	1.56	0.75	-0.31	1.26	1.52
Shares, basic (weighted)	74.1	74.1	74.1	74.6	75.5	69.7	64.7	167	222	200
Shares, diluted (weighted)	74.1	74.1	74.4	75.9	76.1	318	65.1	167	224	204
Dividend per share									0.06

Balance sheet

	FY2016	FY2018	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	119	300	196	187	592	423	246	259	125	177
Inventory		188	172	220	235	244	270	263	286	339
Other current assets		321	61	85	110	56	110	75	94	98
Total current assets		2,084	1,179	1,199	1,879	1,511	1,431	1,406	1,193	1,319
Property, plant and equipment		442	438	471	505	485	470	477	449	462
Lease right-of-use assets				35	36	51	44	40	52	49
Goodwill		193	193	193	193	193	193	193	193	193
Other non-current assets		2	92	108	135	200	281	206	224	172
Total assets		2,997	2,124	2,275	3,017	2,706	2,637	2,527	2,276	2,367
Accounts payable		860	916	1,009	1,019	1,006	1,048	1,074	972	1,061
Accrued liabilities		571	374	310	242	295	320	293	299	295
Deferred revenue		7	2	3	2	5	8	9	8	10
Short-term debt			23	4	0	7	7	7	7	7
Total current liabilities		2,548	1,440	1,392	1,831	1,508	1,375	1,374	1,278	1,363
Long-term debt			1,569	1,409	1,082	1,181	1,148	1,643	1,464	1,411
Lease liabilities				28	15	42	36	33	42	38
Other non-current liabilities		161	219	274	120	269	205	218	182	363
Total liabilities		5,192	4,641	4,408	5,325	3,174	2,753	3,262	2,949	3,169
Total debt			1,628	1,413	2,081	1,188	1,155	1,650	1,471	1,418
Paid-in capital			5	19	28	1,326	1,333	1,190	1,213	1,240
Retained earnings		-2,433	-2,595	-2,282	-2,207	-1,790	-1,485	-1,922	-1,653	-1,384
Treasury stock								0	-306	-520
Other comprehensive income		238	73	130	-129	-4	36	-3	73	-138
Shareholders' equity	-1,221	-2,195	-2,517	-2,133	-2,308	-468	-116	-735	-673	-802
Total equity	-1,221	-2,195	-2,517	-2,133	-2,308	-468	-116	-735	-673	-802
Total liabilities and equity		2,997	2,124	2,275	3,017	2,706	2,637	2,527	2,276	2,367
Shares outstanding		74	74	74.8	75.8	64.6	64.8	238	206	191

Cash flow statement

	FY2016	FY2018	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	199	-983	1,206	313	80	495	390	261	282	310
Depreciation and amortization	59	64	72	73	86	92	84	90	90	99
Stock-based compensation	12	15	21	18	10	7	11	14	23	27
Deferred income tax	-39	973	-931	-41	-34	-36	46	24	7	9
Change in inventory	2	-46	2	-60	-14	-31	-48	12	-48	-35
Cash from operations	305	71	373	242	25	-310	375	465	408	413
Capital expenditures	-84	-103	-95	-102	-80	-72	-91	-83	-91	-72
Purchases of investments	-659	-651	-21
Sales and maturities of investments	575	712	312
Cash from investing	-182	30	192	-86	-80	-71	-91	-55	-14	-41
Debt issued			1,631
Debt repaid			-6
Share buybacks				0	0	-4	0	-213	-296	-208
Dividends paid					0	0	-83	-42	0	-52
Cash from financing	-149	60	-658	-163	530	139	-482	-403	-520	-326
Exchange rate effect	-1	20	-11
Net change in cash	-27	181	-104	-9	506	-229	-216	12	-134	53
Free cash flow	221	-32	278	140	-55	-382	284	382	317	341
Interest paid	5	5	12	54	63	61	65	89	88	95
Income taxes paid	73	430	76	93	44	61	42	60	64	62

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to March 31, 2026; growth uses fiscal years. Valuation uses the share price of $25.72 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	20.3%	Gross profit / revenue.
Pre-tax margin	11.5%	Pre-tax income / revenue.
Net margin	9.3%	Net income / revenue.
FCF margin	10.3%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	12.3%	Cash from operations / revenue.
Effective tax rate	19.3%	Income tax / pre-tax income, when pre-tax income is positive.
Return on assets (ROA)	14.5%	Net income / average total assets.
SG&A / revenue	6.5%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.8%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.0%	Capital expenditures / revenue.
D&A / revenue	2.8%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	3.1%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-0.2%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	3.4%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	3.7%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	2.3%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	6.3%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	9.9%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-7.4%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	31.1%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	20.6%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	26.5%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	7.7%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	1.2%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	3.3%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	75.2%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	7.6%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	6.3%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y	4.0%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	-3.5%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	-4.7%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-9.1%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	46.3%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	21.8%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.98x	Current assets / current liabilities.
Quick ratio	0.10x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.10x	(Cash + short-term investments) / current liabilities.
Debt / assets	59.7%	Total debt / total assets.
Liabilities / assets	132.9%	Total liabilities / total assets.
Net debt	$1.28B	Total debt - cash - short-term investments. Negative means more cash than debt.
Working capital	-$31.0M	Current assets - current liabilities.
Goodwill and intangibles / assets	8.1%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$974.0M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.56x	Revenue / average total assets.
Fixed asset turnover	8.45x	Revenue / average property, plant and equipment.
Inventory turnover	9.40x	Cost of revenue / average inventory.
Days inventory	39 days	365 x average inventory / cost of revenue.
Days payables	134 days	365 x average accounts payable / cost of revenue.
FCF conversion	110.8%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	16.5%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$1.71	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$19.10	Revenue / diluted weighted shares.
FCF per share	$1.97	Free cash flow / diluted weighted shares.
Operating cash flow per share	$2.36	Cash from operations / diluted weighted shares.
Book value per share	-$4.16	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$5.19	Tangible book value / shares outstanding.
Cash per share	$0.76	(Cash + short-term investments) / shares outstanding.
Payout ratio	16.3%	Dividends paid / net income, when net income is positive.
Dividends / FCF	14.7%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	69.7%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$4.80B	Share price x shares outstanding.
Enterprise value	$6.07B	Market cap + total debt - cash - short-term investments.
P/E	14.0x	Market cap / net income. Only when net income is positive.
P/S	1.30x	Market cap / revenue.
P/FCF	12.6x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	10.5x	Market cap / cash from operations, when positive.
EV/Sales	1.64x	Enterprise value / revenue.
EV/FCF	16.0x	Enterprise value / free cash flow, when both are positive.
FCF yield	7.9%	Free cash flow / market cap.
Earnings yield	7.2%	Net income / market cap (the inverse of P/E).
Dividend yield	1.2%	Dividends paid over the period / market cap.
Shareholder yield	6.7%	(Dividends paid + share buybacks) / market cap.
PEG	0.53x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was Garrett Motion Inc.'s revenue in fiscal 2025?

Garrett Motion Inc. reported revenue of $3.58B for fiscal 2025, 3.1% higher than the year before.

Was Garrett Motion Inc. profitable in fiscal 2025?

Yes. Net income was $310.0M, a net margin of 8.6%.

How much free cash flow did Garrett Motion Inc. generate in fiscal 2025?

Cash from operations of $413.0M minus capital expenditures of $72.0M left free cash flow of $341.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Garrett Motion Inc.